Patents by Inventor Frederick C. Kull

Frederick C. Kull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bombesin antagonists
    Patent number: 5620959
    Abstract: The present invention provides polypeptides of the formula XX.sup.1 TrpX.sup.2 X.sup.3 X.sup.4 X.sup.5 X.sup.6 X.sup.7 NH.sub.2, methods of treatment using the polypeptides, pharmaceutical compositions comprising such polypeptides, and processes for their preparation. The polypeptides possess antagonist properties against bombesin and bombesin-like peptides and are useful in the treatment of malignant disease. M, X, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, X.sup.6, and X.sup.7 are as defined in the specification.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: April 15, 1997
    Assignee: Glaxo Wellcome Inc.
    Inventors: Johann J. Leban, Frederick C. Kull